Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a neurodegenerative condition characterized histopathologically by neuritic plaques and neurofibrillary tangles. The objective of this transcriptional profiling study was to identify both neurosusceptibility and intrinsic neuroprotective factors at the molecular level, not confounded by the downstream consequences of pathology. We thus studied post-mortem cortical tissue in 28 cases that were non-APOE4 carriers (called the APOE3 group) and 13 cases that were APOE4 carriers. As APOE genotype is the major genetic risk factor for late-onset AD, the former group was at low risk for development of the disease and the latter group was at high risk for the disease. Mean age at death was 42 years and none of the brains had histopathology diagnostic of AD at the time of death. We first derived interregional difference scores in expression between cortical tissue from a region relatively invulnerable to AD (primary somatosensory cortex, BA 1/2/3) and an area known to be susceptible to AD pathology (middle temporal gyrus, BA 21). We then contrasted the magnitude of these interregional differences in between-group comparisons of the APOE3 (low risk) and APOE4 (high risk) genotype groups. We identified 70 transcripts that differed significantly between the groups. These included EGFR, CNTFR, CASP6, GRIA2, CTNNB1, FKBPL, LGALS1 and PSMC5. Using real-time quantitative PCR, we validated these findings. In addition, we found regional differences in the expression of APOE itself. We also identified multiple Kyoto pathways that were disrupted in the APOE4 group, including those involved in mitochondrial function, calcium regulation and cell-cycle reentry. To determine the functional significance of our transcriptional findings, we used bioinformatics pathway analyses to demonstrate that the molecules listed above comprised a network of connections with each other, APOE, and APP and MAPT. Overall, our results indicated that the abnormalities that we observed in single transcripts and in signaling pathways were not the consequences of diagnostic plaque and tangle pathology, but preceded it and thus may be a causative link in the long molecular prodrome that results in clinical AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedRestriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
A network-based analysis of systemic inflammation in humans
Program, I. A. H. R. T. I. L. S. C. R., Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. P., et al. (2005) · Nature · doi:10.1038/nature03985 · Cited by 1,429
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585
Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0419 · Cited by 569
Research works printed but not linked: 52
- Haroutunian V, Katsel P, Schmeidler J . Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. Neurobiol Aging 2007; 30: 561–573. · DOI
- Brun A, Gustafson L . Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Archiv fur Psychiatrie und Nervenkrankheiten 1976; 223: 15–33. · DOI · Paper page
- Reddy PH, McWeeney S . Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.[see comment]. Neurobiol Aging 2006; 27: 1060–1077. · DOI
- Katsel PL, Davis KL, Haroutunian V . Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 2005; 63: 41–82. · DOI
- Mirnics K, Levitt P, Lewis DA . DNA microarray analysis of postmortem brain tissue. Int Rev Neurobiol 2004; 60: 153–181. · DOI
- Conejero-Goldberg C, Wang E, Yi C, Goldberg TE, Jones-Brando L, Marincola FM et al. Infectious pathogen detection arrays: viral detection in cell lines and postmortem brain tissue. Biotechniques 2005; 39: 741–751. · doi:10.2144/000112016
- Khachaturian ZS . Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42: 1097–1105. · DOI · Paper page
- Barnes M, Freudenberg J, Thompson S, Aronow B, Pavlidis P . Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res 2005; 33: 5914–5923. · DOI · Paper page
- McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon R . Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 2002; 18: 1462–1469. · DOI · Paper page
- LeBlanc AC . The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2005; 2: 389–402. · DOI · Paper page
- Klaiman G, Petzke TL, Hammond J, Leblanc AC . Targets of caspase-6 activity in human neurons and Alzheimer's disease. Mol Cell Proteomics 2008; 7: 1541–1555. · DOI · Paper page
- Yasuda RP, Ikonomovic MD, Sheffield R, Rubin RT, Wolfe BB, Armstrong DM . Reduction of AMPA-selective glutamate receptor subunits in the entorhinal cortex of patients with Alzheimer's disease pathology: a biochemical study. Brain Res 1995; 678: 161–167. · DOI · Paper page
- Carter TL, Rissman RA, Mishizen-Eberz AJ, Wolfe BB, Hamilton RL, Gandy S et al. Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage. Exp Neurol 2004; 187: 299–309. · DOI
- Altar CA, Vawter MP, Ginsberg SD . Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacol Rev 2009; 34: 18–54. · DOI · Paper page
- Zhang YW, Wang R, Liu Q, Zhang H, Liao FF, Xu H . Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression. Proc Natl Acad Sci USA 2007; 104: 10613–10618. · DOI · Paper page
- Repetto E, Yoon IS, Zheng H, Kang DE . Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway. J Biol Chem 2007; 282: 31504–31516. · DOI · Paper page
- Cha YK, Kim YH, Ahn YH, Koh JY . Epidermal growth factor induces oxidative neuronal injury in cortical culture. J Neurochem 2000; 75: 298–303. · doi:10.1046/j.1471-4159.2000.0750298.x
- Kang CB, Hong Y, Dhe-Paganon S, Yoon HS . FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 2008; 16: 318–325. · DOI · Paper page
- Hoeffer CA, Tang W, Wong H, Santillan A, Patterson RJ, Martinez LA et al. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 2008; 60: 832–845. · DOI · Paper page
- Wang HQ, Nakaya Y, Du Z, Yamane T, Shirane M, Kudo T et al. Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2. Hum Mol Genet 2005; 14: 1889–1902. · DOI · Paper page
- Gutman CR, Strittmatter WJ, Weisgraber KH, Matthew WD . Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J Neurosci 1997; 17: 6114–6121. · DOI · Paper page
- Qu HY, Zhang T, Li XL, Zhou JP, Zhao BQ, Li Q et al. Transducible P11-CNTF rescues the learning and memory impairments induced by amyloid-beta peptide in mice. Eur J Pharmacol 2008; 594: 93–100. · DOI
- Laity JH, Lee BM, Wright PE . Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol 2001; 11: 39–46. · DOI · Paper page
- Maguschak KA, Ressler KJ . Beta-catenin is required for memory consolidation. Nature Neurosci 2008; 11: 1319–1326. · DOI · Paper page
- Sasaki T, Hirabayashi J, Manya H, Kasai K, Endo T . Galectin-1 induces astrocyte differentiation, which leads to production of brain-derived neurotrophic factor. Glycobiology 2004; 14: 357–363. · DOI
- Cooper D, Norling LV, Perretti M . Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow. J Leukoc Biol 2008; 83: 1459–1466. · DOI · Paper page
- La M, Cao TV, Cerchiaro G, Chilton K, Hirabayashi J, Kasai K et al. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am J Pathol 2003; 163: 1505–1515. · DOI
- Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 2003; 22: 3307–3318. · DOI · Paper page
- Zhang JY, Liu SJ, Li HL, Wang JZ . Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system. J Neural Transm 2005; 112: 547–555. · DOI
- Lopez Salon M, Pasquini L, Besio Moreno M, Pasquini JM, Soto E . Relationship between beta-amyloid degradation and the 26S proteasome in neural cells. Exp Neurol 2003; 180: 131–143. · DOI · Paper page
- Cecarini V, Bonfili L, Amici M, Angeletti M, Keller JN, Eleuteri AM . Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes. Brain Res 2008; 1209: 8–18. · DOI
- Hoglinger GU, Carrard G, Michel PP, Medja F, Lombes A, Ruberg M et al. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J Neurochem 2003; 86: 1297–1307. · DOI · Paper page
- Stutzmann GE . The pathogenesis of Alzheimer's disease is it a lifelong ‘calciumopathy’? Neuroscientist 2007; 13: 546–559. · DOI · Paper page
- LaFerla FM . Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002; 3: 862–872. · DOI · Paper page
- Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A et al. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 2008; 133: 1149–1161. · DOI · Paper page
- Mudher A, Lovestone S . Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci 2002; 25: 22–26. · DOI · Paper page
- De Strooper B, Annaert W . Where Notch and Wnt signaling meet. The presenilin hub. J Cell Biol 2001; 152: 785–794. · DOI
- Herrup K, Arendt T . Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease.[see comment]. J Alzheimers Dis 2002; 4: 243–247. · DOI
- Herrup K, Neve R, Ackerman SL, Copani A . Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 2004; 24: 9232–9239. · DOI · Paper page
- Mattson MP, Keller JN, Begley JG . Evidence for synaptic apoptosis. Exp Neurol 1998; 153: 35–48. · DOI · Paper page
- Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC . Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 2007; 170: 1200–1209. · DOI
- Zhong N, Scearce-Levie K, Ramaswamy G, Weisgraber KH . Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice. Alzheimers Dement 2008; 4: 179–192. · DOI · Paper page
- Mahley RW, Huang Y . Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurologica Scandinavica Supplementum 2006; 185: 8–14. · DOI · Paper page
- Reddy PH, Beal MF . Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Rev 2005; 49: 618–632. · DOI · Paper page
- Lin MT, Beal MF . Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787–795. · DOI · Paper page
- Starkov AA, Beal FM . Portal to Alzheimer's disease.[comment]. Nat Med 2008; 14: 1020–1021. · DOI · Paper page
- Smith MA, Drew KL, Nunomura A, Takeda A, Hirai K, Zhu X et al. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem Int 2002; 40: 527–531. · DOI
- Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Pro Natl Acad Sci USA 2009; 106: 20057–20062. · DOI · Paper page
- Hardy J, Selkoe DJ . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.[see comment]. [published erratum appears in Science 2002; 297: 2209] Science 2002; 297: 353–356. · DOI · Paper page
- Xu PT, Li YJ, Qin XJ, Scherzer CR, Xu H, Schmechel DE et al. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis 2006; 21: 256–275. · DOI · Paper page
- Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ . Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000; 48: 77–87. · DOI · Paper page
- Palop JJ, Chin J, Mucke L . A network dysfunction perspective on neurodegenerative diseases. Nature 2006; 443: 768–773. · DOI · Paper page
Cited by
Age, APOE and sex: triad of risk of Alzheimer’s disease.
Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.012 · Cited by 627
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570
“Given the primary role of beta-amyloid in AD, it is presumed that the effect of APOE4 on beta-amyloid accumulation is the chief, though perhaps not the sole (Conejero-Goldberg et al., 2011; Shi et al., 2017; Reiman et al., 2001; Yu et al., 2014), mechanism linking APOE4 to AD risk.”
Apolipoprotein e sets the stage: response to injury triggers neuropathology
Mahley, R. W., & Huang, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.020 · Cited by 412
Apolipoprotein E in Alzheimer's Disease: An Update
Yu, J.-T., Tan, L., & Hardy, J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014300 · Cited by 394
“Moreover, in the postmortem cortex of younger individuals, APOE ε4 carriers have greater oxidative mitochondrial dysfunction than do noncarriers (Conejero-Goldberg et al. 2011, Valla et al. 2010).”
BackgroundGomar, J. J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.96 · Cited by 340
Metadata
- Authors
- Conejero-Goldberg, C., Hyde, T. M., Chen, S., Dreses-Werringloer, U., Herman, M. M., Kleinman, J. E., Davies, P., & Goldberg, T. E.
- Venue
- Molecular Psychiatry
- Published
- 2010-05-18
- Volume
- 16
- Issue
- 8
- Pages
- 836-847
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2044692031
- Cited by
- 53
- References
- 17
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype. https://app.cochat.ai/papers/10.1038/mp.2010.57
- The paper
- Conejero-Goldberg, C., Hyde, T. M., Chen, S., Dreses-Werringloer, U., Herman, M. M., Kleinman, J. E., Davies, P., & Goldberg, T. E. (2011). Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype. Molecular Psychiatry. https://doi.org/10.1038/mp.2010.57
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.